Abstracts

Het is niet meer mogelijk om abstracts in te dienen. Abstract indieners zullen eind augustus bericht krijgen over de status van de ingediende abstracts. 


POSTERS
On behalf of the scientific committee it is our pleasure to invite you to submit an abstract for IBRD22. Please read the guidelines on this page carefully before you submit your abstract. Abstracts will be reviewed by the IBRD22 scientific board.

The abstract submission deadline is: Friday 5 August 2022 at 23:59 hrs.

GUIDELINES 
Here you will find how to submit your abstract and all the guidelines that you need to take into account. Please read them carefully before starting the submission process.
▪ Abstracts can only be submitted by email as a PDF document: registrations@congresscare.com.
▪ The acceptable length of the abstract is a maximum of 450 words.
▪ It is not possible to add tables, figures or images to your abstract. 
▪ It is possible to submit your abstract until August 5st, 2022.
▪ After submission of the abstract it is not possible to make any changes.
▪ The presenting author of the abstract must be registered for the meeting before August 26th, 2022.

Topics
▪ Innovations to tackle delay in RD diagnostics
▪ Screening of the newborn child and improvement of prevention
▪ Impact of patient involvement on RD policy
▪ Pricing of orphan drugs
▪ Regulatory and access challenges in orphan drugs
▪ (other generic topics relevant to the entire field of rare diseases and orphan drugs)

ABSTRACT FORMAT
Please use the following headings in your abstract so that the Scientific Committee can evaluate the quality and completeness of your abstract:

▪ Title
▪ Authors with affiliations
▪ Topic from the list above
▪ Introduction
▪ Aims (optional)
▪ Methods
▪ Results
▪ Conclusion

Note: The presenting author of the abstract must be registered for the meeting.

Please, submit your abstract by sending your document to registrations@congresscare.com. Make sure to mention the congress name (IBRD22) in the subject of the email.